5-(Bromomethyl)-2-methylpyrimidin-4-amine hydrobromide, 95.0%, 100mg

4-(1-naphthyl)pyrimidin-2-amine, 5g

2,8-DIMETHYL[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLAMINE, 95.0%, 25g

Methanesulfonic acid, 70%, for synthesis, 100 ml, glass packaging

Nirogacestat, 98.76%, 50mg

(2S,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride, 95.0%, 1g

4-(5-Pyrimidinyl)aniline, 95.0%, 2.5g

2-(1H-Pyrazol-4-yl)phenol, 1g

2-Fluoro-6-pyridinecarboxylic acid, 97.0%, 500g

1-(Pyridin-4-yl)cyclopropanecarbonitrile, 95.0%, 250mg

2',7'-Dichlorofluorescein, >95.0%(HPLC), 100g

N-(tert-Butoxycarbonyl)-D-proline>98.0%(HPLC)(T)25g

2-Aminophenyl Phenyl Sulfide>98.0%(GC)500g